Another study on the RET K666N mutation in a patient with MTC and bilateral pheochromocytoma (PHEO), who was homozygous for RET K666N, described important aspects of this mutation’s influence on the development of MTC and PHEOs in patients with MEN2 syndrome. Here, RET is linked to medullary thyroid gland carcinoma.